Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Jan 2012 for Pharmasset Inc, €23.9M.
Insider track record
Disclosed buys
2
Disclosed sells
2
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kurt Leutzinger: trading record in brief
All filings by Kurt Leutzinger on record concern Pharmasset Inc. Over a trading history stretching from 9 August 2007 to 12 January 2012, the count stands at 8 filings.
Both buying and selling appear: 2 purchases worth €51k, against 2 sales worth €1.5M. Taken together, the sales exceed the purchases by €1.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise.
On 17 January 2012 came the latest disclosure, a transaction for €8.1M in Pharmasset Inc. The latest purchase dates back some time: it was published 6,797 days ago, on 14 March 2008. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kurt Leutzinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
222,232 shares@ US$137.00Common StockSEC:0001209191-12-003887:0
75,300 shares@ US$137.00Common StockSEC:0001209191-12-003887:1
11,287 shares@ US$102.88Common Stock, $.001 par value per shareSEC:0001192482-11-000121:0
9,546 shares@ US$102.61Common Stock, $.001 par value per shareSEC:0001192482-11-000119:0
4,000 shares@ US$15.60Common StockSEC:0001192482-08-000090:0
Canonical exit: 10 Jun 2008 (T+90)
1,000 shares@ US$16.32Common StockSEC:0001192482-08-000090:1
Canonical exit: 11 Jun 2008 (T+90)
20,833 shares@ US$3.00Common StockSEC:0001192482-07-000446:0
7 of 7 declarations
